Cardiff Oncology

$8.58
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.44 (-4.89%) Today

+$0.02 (+0.23%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRDF and other stocks, options, and ETFs commission-free!

About CRDF

Cardiff Oncology, Inc. Common Stock, also called Cardiff Oncology, is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer.

CEO

Mark Erlander

Employees

Headquarters

San Diego, California

Founded

1999

Market Cap

333.59M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

771.86K

High Today

$9.19

Low Today

$8.51

Open Price

$8.93

Volume

890.63K

52 Week High

$25.50

52 Week Low

$0.825

CRDF Earnings

-$0.71

-$0.47

-$0.24

$0.00

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Q4 FY20

Q1 FY21

Estimated

— per share

Actual

Expected May 6, After Hours